Skip to content
Medical Health Aged Care, Political

For 50,000 Australians October 5 is the one day each year when they can be seen and heard.

Story for Saturday. < 1 mins read

Most Australians would be completely unaware of the impact having a stoma has on a person’s quality of life.  A stoma is surgically created opening in the abdomen to remove body waste, such as faeces and urine. Many conditions can lead to someone needing a stoma, including colorectal cancer, inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, bladder cancer, injury trauma, and congenital defects.

World Ostomy Day is about spreading awareness and advocating for those living with stomas. The Stoma Industry Association (SIA) knows the importance of speaking out against the silence and shining a light on this challenging and often stigmatised condition. We also want to acknowledge all the tremendous work done by Ostomy Associations and Stomal Therapy Nurses (STNs) in supporting this neglected patient group.

Appliances used to manage the stoma output are subsidised by the Commonwealth funded Stoma Appliance Scheme (SAS). The Government is reviewing it right now. There have been six reviews of the SAS. The only change to ever result from any of these was the 2012 freezing of the prices Government pays for stoma products.  

The current review must not become another missed opportunity to improve the lives of 50,000 Australian ostomates. On World Ostomy Day on 5 October 2024 we’re asking the Australian Government to increase investment in the products 50,000 Australian ostomates depend on. 


Key Facts:

https://www.stomaindustryassociation.com.au/stoma-campaign


About us:

Statement attributed to:   Matthew Dalton, Chair, Stoma Industry Association (SIA)


Contact details:

Tim Cook Tel: 0428 862 436 

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.